Pilot Study to Investigate Therapeutic Potential of Targeting Sialic Acid Modifications on VEGFR3 in Recurrent Respiratory Papillomatosis Grant

Pilot Study to Investigate Therapeutic Potential of Targeting Sialic Acid Modifications on VEGFR3 in Recurrent Respiratory Papillomatosis .

date/time interval

  • April 1, 2025 - April 1, 2026

awarded by

sponsor award ID

  • Grant 03/18/2025

contributor